Michele Robertson

4.7k total citations · 1 hit paper
41 papers, 2.0k citations indexed

About

Michele Robertson is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Michele Robertson has authored 41 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 15 papers in Cardiology and Cardiovascular Medicine and 11 papers in Epidemiology. Recurrent topics in Michele Robertson's work include Lipoproteins and Cardiovascular Health (13 papers), Substance Abuse Treatment and Outcomes (7 papers) and Heart Failure Treatment and Management (7 papers). Michele Robertson is often cited by papers focused on Lipoproteins and Cardiovascular Health (13 papers), Substance Abuse Treatment and Outcomes (7 papers) and Heart Failure Treatment and Management (7 papers). Michele Robertson collaborates with scholars based in United Kingdom, United States and Netherlands. Michele Robertson's co-authors include Ian Ford, Roberto Ferrari, Kim Fox, Michał Tendera, Philippe Gabríel Steg, Joanne Neale, Ian Ford, J. Wouter Jukema, John J.V. McMurray and Neil McKeganey and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Michele Robertson

40 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

2008 593 citations Ian Ford, Michele Robertson et al. profile →

Peers

Countries citing papers authored by Michele Robertson

Since Specialization

Citations

This map shows the geographic impact of Michele Robertson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Robertson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Robertson more than expected).

Fields of papers citing papers by Michele Robertson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Robertson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Robertson. The network helps show where Michele Robertson may publish in the future.

Co-authorship network of co-authors of Michele Robertson

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Robertson. A scholar is included among the top collaborators of Michele Robertson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Robertson. Michele Robertson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recurrent Event Analyses in Patients Receiving Maintenance Dialysis and the Effect of Higher- Versus Lower-Dose Chronic Intravenous Iron Therapy: A Report Focusing on Heart Failure Events from the PIVOTAL Trial 2025 ·European Journal of Heart Failure ·Stefan D. Anker, Michele Robertson, John J.V. McMurray, Pardeep S. Jhund, Claire White, (unknown), Sunil Bhandari, Ken Farrington, Philip A. Kalra, Khawaja M. Talha, Patrick B. Mark, Charles Tomson, David C. Wheeler, C. G. Winearls, Iain C. Macdougall, (unknown)	0
2	Predictors of quality of life in patients within the first year of commencing haemodialysis based on baseline data from the PIVOTAL trial and associations with the study outcomes 2023 ·Journal of Nephrology ·Sunil Bhandari, Patrick S. Parfrey, Claire White, Stefan D. Anker, Kenneth Farrington, Ian Ford, Philip A. Kalra, John J.V. McMurray, Michele Robertson, Charles Tomson, David C. Wheeler, Iain C. Macdougall	4
3	Heart Failure Hospitalization in Adults Receiving Hemodialysis and the Effect of Intravenous Iron Therapy 2021 ·JACC Heart Failure ·Pardeep S. Jhund, Mark C. Petrie, Michele Robertson, Patrick B. Mark, Michael R. MacDonald, Eugene Connolly, Stefan D. Anker, Sunil Bhandari, Kenneth Farrington, Philip A. Kalra, David C. Wheeler, Charles Tomson, Ian Ford, John J.V. McMurray, Iain C. Macdougall	14
4	Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL Trial 2020 ·Journal of the American Society of Nephrology ·Iain C. Macdougall, Sunil Bhandari, Claire White, Stefan D. Anker, Kenneth Farrington, Philip A. Kalra, Patrick B. Mark, John J.V. McMurray, (unknown), Michele Robertson, Charles Tomson, David C. Wheeler, Christopher G. Winearls, Ian Ford	51
5	Cardiac Resynchronization Therapy in Patients With Heart Failure and Narrow QRS Complexes 2018 ·Journal of the American College of Cardiology ·Bhupendar Tayal, John Gorcsan, Jeroen J. Bax, Niels Risum, Niels Thue Olsen, G. André Ng, William T. Abraham, Jeffrey Borer, Kenneth Dickstein, Daniel Gras, Henry Krum, Josép Brugada, Michele Robertson, Ian Ford, Johannes Holzmeister, Frank Ruschitzka, Peter Søgaard	10
6	Effect of Cardiac Resynchronization Therapy in Patients with Diabetes Randomized in EchoCRT 2016 ·European Journal of Heart Failure ·Matthias P. Nägele, Jan Steffel, Michele Robertson, G. André Ng, Andreas J. Flammer, Jeroen J. Bax, Jeffrey Borer, Kenneth Dickstein, Ian Ford, John Gorcsan, Daniel Gras, Henry Krum, Peter Søgaard, Johannes Holzmeister, William T. Abraham, Josép Brugada, Frank Ruschitzka	6
7	Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial) 2015 ·The American Journal of Cardiology ·Michael Böhm, Michele Robertson, Ian Ford, Jeffrey Borer, Michel Komajda, Ingrid Kindermann, Christoph Maack, Mitja Lainščak, Karl Swedberg, Luigi Tavazzi	47
8	The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trial 2015 ·European Heart Journal ·Jan Steffel, Michele Robertson, G. André Ng, William T. Abraham, Jeroen J. Bax, Jeffrey Borer, Kenneth Dickstein, Ian Ford, John Gorcsan, Daniel Gras, Henry Krum, Peter Søgaard, Johannes Holzmeister, Josép Brugada, Frank Ruschitzka	39
9	The Effect of Heart Rate Reduction with Ivabradine on Renal Function in Patients with Chronic Heart Failure: An Analysis from SHIFT 2014 ·European Journal of Heart Failure ·Adriaan A. Voors, Dirk J. van Veldhuisen, Michele Robertson, Ian Ford, Jeffrey Borer, Michael Böhm, Michel Komajda, Karl Swedberg, Luigi Tavazzi	43
10	ABCA1 gene variation and heart disease risk reduction in the elderly during pravastatin treatment 2014 ·Atherosclerosis ·(unknown), Eliana Polisecki, Ernst J. Schaefer, Stella Trompet, Michele Robertson, Ian Ford, J. Wouter Jukema, Anton J.M. de Craen, Christopher J. Packard, Brendan M. Buckley, Kouji Kajinami	9
11	Clinical profile, outcomes, and ivabradine effects in patients with chronic obstructive pulmonary disease and chronic heart failure: The SHIFT trial analysis 2013 ·European Respiratory Journal ·Mitja Lainščak, Luigi Tavazzi, Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey Borer, Michele Robertson, Ian Ford	1
12	Effect of Statins on Venous Thromboembolic Events: A Meta-analysis of Published and Unpublished Evidence from Randomised Controlled Trials 2012 ·PLoS Medicine ·Kazem Rahimi, Neeraj Bhala, Pieter W. Kamphuisen, Jonathan Emberson, Sara Biere‐Rafi, Vera Krane, Michele Robertson, John Wikstrand, John J.V. McMurray	77
13	KIF6, LPA, TAS2R50, and VAMP8 genetic variation, low density lipoprotein cholesterol lowering response to pravastatin, and heart disease risk reduction in the elderly 2011 ·Atherosclerosis ·(unknown), Eliana Polisecki, Kouji Kajinami, Stella Trompet, Michele Robertson, Ian Ford, J. Wouter Jukema, Anton J.M. de Craen, Rudi G. J. Westendorp, James Shepherd, Christopher J. Packard, Brendan M. Buckley, Ernst J. Schaefer	27
14	Genetic variation at the SLCO1B1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly 2011 ·Atherosclerosis ·(unknown), Eliana Polisecki, Kouji Kajinami, Stella Trompet, Michele Robertson, Ian Ford, J. Wouter Jukema, Anton J.M. de Craen, Rudi G. J. Westendorp, James Shepherd, Christopher J. Packard, Brendan M. Buckley, Ernst J. Schaefer	29
15	Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly 2009 ·Journal of Lipid Research ·Eliana Polisecki, Inga Peter, Jason S. Simon, Robert A. Hegele, Michele Robertson, Ian Ford, James Shepherd, Christopher J. Packard, J. Wouter Jukema, Anton J.M. de Craen, Rudi G. J. Westendorp, Brendan M. Buckley, Ernst J. Schaefer	49
16	Lipoprotein-associated phospholipase A2, inflammatory biomarkers, and risk of cardiovascular disease in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) 2009 ·Atherosclerosis ·Muriel Caslake, Chris J. Packard, Michele Robertson, Josephine Cooney, Jeanenne J. Nelson, Ian Ford, Allan Gaw, J. Wouter Jukema, Peter W. Macfarlane, David J. Stott, James Shepherd	20
17	Cholesterol absorption and synthesis markers in individuals with and without a CHD event during pravastatin therapy: insights from the PROSPER trial 2009 ·Journal of Lipid Research ·Nirupa R. Matthan, Nancy Resteghini, Michele Robertson, Ian Ford, James Shepherd, Chris J. Packard, Brendan M. Buckley, J. Wouter Jukema, Alice H. Lichtenstein, Ernst J. Schaefer	43
18	Occurrence of lactational mastitis and medical management: A prospective cohort study in Glasgow 2008 ·International Breastfeeding Journal ·Jane Scott, Michele Robertson, Julie Fitzpatrick, Christopher G. Knight, (unknown)	56
19	‘Topping up’ methadone: An analysis of patterns of heroin use among a treatment sample of Scottish drug users 2008 ·Public Health ·Michael Bloor, John L. McIntosh, Neil McKeganey, Michele Robertson	11
20	Homelessness among problem drug users: prevalence, risk factors and trigger events 2006 ·Health & Social Care in the Community ·Peter A. Kemp, Joanne Neale, Michele Robertson	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact